Soleus Capital Management, L.P. Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$555.0B
Holdings
72
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (72 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BCABBIOATLA INC | 3,179,362 | $161.6B | 29.12% | |
| 2 | EPIEURESSA PHARMA INC | 2,070,052 | $60.1B | 10.84% | |
| 3 | —THERATECHNOLOGIES INC | 6,951,347 | $26.9B | 4.84% | |
| 4 | OPHTEURIVERIC BIO INC | 3,380,979 | $20.9B | 3.76% | |
| 5 | LNTHLANTHEUS HLDGS INC | 967,372 | $20.7B | 3.72% | |
| 6 | CCCCC4 THERAPEUTICS INC | 464,068 | $17.2B | 3.09% | |
| 7 | KRYSKRYSTAL BIOTECH INC | 166,844 | $12.9B | 2.32% | |
| 8 | AZNASTRAZENECA PLC | 258,446 | $12.8B | 2.32% | |
| 9 | XENEXENON PHARMACEUTICALS INC | 708,117 | $12.7B | 2.28% | |
| 10 | IRMDIRADIMED CORP | 482,070 | $12.4B | 2.24% | |
| 11 | —VESPER HEALTHCARE ACQSTN COR | 920,716 | $9.9B | 1.79% | |
| 12 | GLTOUSDGALECTO INC | 1,512,648 | $9.2B | 1.66% | |
| 13 | SU6SURMODICS INC | 154,275 | $8.7B | 1.56% | |
| 14 | INBXUSDINHIBRX INC | 401,493 | $8.1B | 1.45% | |
| 15 | NTRANATERA INC | 78,239 | $7.9B | 1.43% | |
| 16 | —ITAMAR MED LTD | 270,080 | $6.5B | 1.17% | |
| 17 | —MISONIX INC | 301,333 | $5.9B | 1.06% | |
| 18 | PCVXVAXCYTE INC | 293,650 | $5.8B | 1.05% | |
| 19 | LYRALYRA THERAPEUTICS INC | 475,814 | $5.5B | 0.99% | |
| 20 | ASMBASSEMBLY BIOSCIENCES INC | 1,122,000 | $5.2B | 0.93% | |
| 21 | MDXGMIMEDX GROUP INC | 500,000 | $5.2B | 0.93% | |
| 22 | —FLEXION THERAPEUTICS INC | 522,500 | $4.7B | 0.84% | |
| 23 | SPRYSILVERBACK THERAPEUTICS INC | 97,256 | $4.2B | 0.76% | |
| 24 | EX9EXELIXIS INC | 182,347 | $4.1B | 0.74% | |
| 25 | RPTXREPARE THERAPEUTICS INC | 133,324 | $4.1B | 0.74% | |
| 26 | ALXNALEXION PHARMACEUTICALS INC | 25,318 | $3.9B | 0.70% | |
| 27 | ESTAESTABLISHMENT LABS HLDGS INC | 61,151 | $3.8B | 0.69% | |
| 28 | FDMT4D MOLECULAR THERAPEUTICS IN | 86,100 | $3.7B | 0.67% | |
| 29 | CUTREURCUTERA INC | 120,000 | $3.6B | 0.65% | |
| 30 | PHGKONINKLIJKE PHILIPS N V | 61,050 | $3.5B | 0.63% | |
| 31 | DRIOEURDARIOHEALTH CORP | 178,814 | $3.4B | 0.62% | |
| 32 | RFLRAFAEL HLDGS INC | 85,637 | $3.4B | 0.62% | |
| 33 | —KINNATE BIOPHARMA INC | 109,000 | $3.4B | 0.61% | |
| 34 | NVCRNOVOCURE LTD | 25,325 | $3.3B | 0.60% | |
| 35 | GOSS 5 06/01/27GOSSAMER BIO INC | 3,750,000 | $3.3B | 0.60% | |
| 36 | NVLSEURALPINE IMMUNE SCIENCES INC | 313,064 | $3.3B | 0.60% | |
| 37 | EWTXEDGEWISE THERAPEUTICS INC | 100,000 | $3.3B | 0.59% | |
| 38 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 1,950,000 | $3.2B | 0.58% | |
| 39 | —ARYA SCIENCES ACQU CORP IV | 300,000 | $3.1B | 0.57% | |
| 40 | —TCR2 THERAPEUTICS INC | 142,137 | $3.1B | 0.57% | |
| 41 | SIENUSDSIENTRA INC | 377,900 | $2.8B | 0.50% | |
| 42 | DYNDYNE THERAPEUTICS INC | 174,360 | $2.7B | 0.49% | |
| 43 | RVMDREVOLUTION MEDICINES INC | 57,200 | $2.6B | 0.47% | |
| 44 | DC4DEXCOM INC | 6,935 | $2.5B | 0.45% | |
| 45 | RNAAVIDITY BIOSCIENCES INC | 109,130 | $2.4B | 0.43% | |
| 46 | MRKMERCK & CO. INC | 30,106 | $2.3B | 0.42% | |
| 47 | NARIUSDINARI MED INC | 21,450 | $2.3B | 0.41% | |
| 48 | —CATABASIS PHARMACEUTICALS IN | 775,000 | $2.2B | 0.40% | |
| 49 | NEONEOGENOMICS INC | 45,951 | $2.2B | 0.40% | |
| 50 | EDAEDAP TMS S A | 249,566 | $2.1B | 0.38% | |
| 51 | RNLXUSDRENALYTIX AI PLC | 80,000 | $2.1B | 0.37% | |
| 52 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 213,519 | $1.9B | 0.34% | |
| 53 | STAASTAAR SURGICAL CO | 16,700 | $1.8B | 0.32% | |
| 54 | CMPSCOMPASS PATHWAYS PLC | 42,743 | $1.6B | 0.28% | |
| 55 | —ONCOCYTE CORP | 297,000 | $1.5B | 0.28% | |
| 56 | OSH3EUROAK STR HEALTH INC | 27,612 | $1.5B | 0.27% | |
| 57 | —DEERFIELD HEALTHCARE TECH AC | 118,900 | $1.4B | 0.26% | |
| 58 | MORFMORPHIC HLDG INC | 21,500 | $1.4B | 0.25% | |
| 59 | SRRKSCHOLAR ROCK HLDG CORP | 26,101 | $1.3B | 0.24% | |
| 60 | —KADMON HLDGS INC | 336,442 | $1.3B | 0.24% | |
| 61 | PIRSPIERIS PHARMACEUTICALS INC | 500,000 | $1.3B | 0.23% | |
| 62 | —MAGENTA THERAPEUTICS INC | 100,000 | $1.2B | 0.21% | |
| 63 | VRDNVIRIDIAN THERAPEUTICS INC | 67,685 | $1.1B | 0.20% | |
| 64 | TREURTRILLIUM THERAPEUTICS INC | 103,819 | $1.1B | 0.20% | |
| 65 | KYMRKYMERA THERAPEUTICS INC | 28,116 | $1.1B | 0.20% | |
| 66 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 99,992 | $986.0M | 0.18% | |
| 67 | —ONCORUS INC | 66,722 | $929.0M | 0.17% | |
| 68 | RVNCEURREVANCE THERAPEUTICS INC | 31,136 | $870.0M | 0.16% | |
| 69 | MRTXEURMIRATI THERAPEUTICS INC | 3,466 | $594.0M | 0.11% | |
| 70 | —TURNING POINT THERAPEUTICS I | 5,577 | $528.0M | 0.10% | |
| 71 | —HIMS & HERS HEALTH INC | 91,793 | $404.0M | 0.07% | |
| 72 | CRDFCARDIFF ONCOLOGY INC | 42,684 | $395.0M | 0.07% |